Found: 99
Select item for more details and to access through your institution.
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00604-9
- By:
- Publication type:
- Article
Oral and anal microbiome from HIV-exposed individuals: role of host-associated factors in taxa composition and metabolic pathways.
- Published in:
- NPJ Biofilms & Microbiomes, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41522-023-00413-4
- By:
- Publication type:
- Article
TRANSGENDER WOMEN BASELINE PROFILE IN TRANSCITAR: TRANS-SPECIFIC COHORT IN ARGENTINA.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 343
- By:
- Publication type:
- Article
Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-022-00488-7
- By:
- Publication type:
- Article
Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0279996
- By:
- Publication type:
- Article
"If I'm at home, I do it at home": Qualitative study on HIV self-testing among transgender women in Argentina.
- Published in:
- International Journal of STD & AIDS, 2023, v. 34, n. 1, p. 25, doi. 10.1177/09564624221132624
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine by Baseline Regimen in Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 271
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine (DTG/3TC) in Treatment-Experienced, Virologically Suppressed PLHIV Aged ≥50 Years: Pooled Results From the TANGO and SALSA Studies.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 273
- By:
- Publication type:
- Article
Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV.
- Published in:
- HIV Medicine, 2022, v. 23, n. 9, p. 936, doi. 10.1111/hiv.13288
- By:
- Publication type:
- Article
Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.904689
- By:
- Publication type:
- Article
Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
HIV and aging, biological mechanisms, and therapies: What do we know?
- Published in:
- AIDS Reviews, 2022, v. 24, n. 2, p. 79, doi. 10.24875/AIDSRev.21000085
- By:
- Publication type:
- Article
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 4, p. 1, doi. 10.1093/ofid/ofac068
- By:
- Publication type:
- Article
Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies.
- Published in:
- Antiviral Therapy, 2021, v. 26, n. 6-8, p. 95, doi. 10.1177/13596535211062388
- By:
- Publication type:
- Article
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24673-w
- By:
- Publication type:
- Article
Cumulative Burden of Mental Health Factors and Engagement in HIV Care in Argentina.
- Published in:
- International Journal of Behavioral Medicine, 2021, v. 28, n. 3, p. 318, doi. 10.1007/s12529-020-09921-5
- By:
- Publication type:
- Article
Correction to: Cumulative Burden of Mental Health Factors and Engagement in HIV Care in Argentina.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Acceptability of dual HIV/syphilis rapid test in community- and home-based testing strategy among transgender women in Buenos Aires, Argentina.
- Published in:
- International Journal of STD & AIDS, 2021, v. 32, n. 6, p. 501, doi. 10.1177/0956462420979852
- By:
- Publication type:
- Article
Reduction of Gender Identity Stigma and Improvements in Mental Health Among Transgender Women Initiating HIV Treatment in a Trans-Sensitive Clinic in Argentina.
- Published in:
- Transgender Health, 2020, v. 5, n. 4, p. 216, doi. 10.1089/trgh.2020.0005
- By:
- Publication type:
- Article
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus–1: An Integrated Safety Analysis.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1336, doi. 10.1093/cid/ciz423
- By:
- Publication type:
- Article
Home-based HIV testing: Using different strategies among transgender women in Argentina.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230429
- By:
- Publication type:
- Article
The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 3, p. 1, doi. 10.1002/jia2.25468
- By:
- Publication type:
- Article
Suicidal Ideation Among Adults Re-engaging in HIV Care in Argentina.
- Published in:
- AIDS & Behavior, 2019, v. 23, n. 12, p. 3427, doi. 10.1007/s10461-019-02526-4
- By:
- Publication type:
- Article
NUEVAS ESTRATEGIAS PARA EL CONTROL Y LA PREVENCIÓN DE LA INFECCIÓN POR HIV.
- Published in:
- Medicina (Buenos Aires), 2019, v. 79, p. 534
- By:
- Publication type:
- Article
Women of Reproductive Age Living with HIV in Argentina: Unique Challenges for Reengagement in Care.
- Published in:
- Journal of the International Association of Providers of AIDS Care, 2019, v. 18, p. 1, doi. 10.1177/2325958219883250
- By:
- Publication type:
- Article
Women of Reproductive Age Living with HIV in Argentina: Unique Challenges for Reengagement in Care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
NUEVAS ESTRATEGIAS PARA EL CONTROL Y LA PREVENCIÓN DE LA INFECCIÓN POR HIV.
- Published in:
- Medicina (Buenos Aires), 2019, v. 79, n. 6, p. 534
- By:
- Publication type:
- Article
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221653
- By:
- Publication type:
- Article
Liver cirrhosis in HIV/HCV‐coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4<sup>+</sup> T‐cells.
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 9, p. N.PAG, doi. 10.1002/jia2.25375
- By:
- Publication type:
- Article
Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-38547-1
- By:
- Publication type:
- Article
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. 480, doi. 10.1093/jac/dky433
- By:
- Publication type:
- Article
NÃO INFERIORIDADE DE EFICÁCIA DE DOLUTEGRAVIR (DTG) MAIS LAMIVUDIDINA (3 TC) VERSUS DTG MAIS DOSE FIXA COMBINADA DE TENOFOVIR/EMTRICITABINA (TDF/FTC) EM ADULTOS VIRGENS DE TRATAMENTO ANTIRRETROVIRAL QUE VIVEM COM HIV-1: RESULTADOS DE 48 SEMANAS DOS ESTU.
- Published in:
- Brazilian Journal of Infectious Diseases, 2018, v. 22, p. 56, doi. 10.1016/j.bjid.2018.10.106
- By:
- Publication type:
- Article
Physician-delivered motivational interviewing to improve adherence and retention in care among challenging HIV-infected patients in Argentina (COPA2): study protocol for a cluster randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expert consensus statement on the science of HIV in the context of criminal law.
- Published in:
- Journal of the International AIDS Society, 2018, v. 21, n. 7, p. 1, doi. 10.1002/jia2.25161
- By:
- Publication type:
- Article
Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America.
- Published in:
- Infectious Agents & Cancer, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13027-018-0188-3
- By:
- Publication type:
- Article
Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.
- Published in:
- Journal of the International AIDS Society, 2018, v. 21, n. 3, p. 1, doi. 10.1002/jia2.25088
- By:
- Publication type:
- Article
A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179769
- By:
- Publication type:
- Article
Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178721
- By:
- Publication type:
- Article
Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.01.21678
- By:
- Publication type:
- Article
Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.01.21678
- By:
- Publication type:
- Article
Dolutegravir–lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, n. 1, p. 1, doi. 10.7448/IAS.20.01.21678
- By:
- Publication type:
- Article
The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital.
- Published in:
- Pan American Journal of Public Health, 2016, v. 40, n. 6, p. 448
- By:
- Publication type:
- Article
Improving Adherence to Care Among 'Hard to Reach' HIV-Infected Patients in Argentina.
- Published in:
- AIDS & Behavior, 2016, v. 20, n. 5, p. 987, doi. 10.1007/s10461-015-1133-8
- By:
- Publication type:
- Article
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148231
- By:
- Publication type:
- Article
Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression.
- Published in:
- Journal of the International AIDS Society, 2016, v. 19, n. 1, p. 1, doi. 10.7448/IAS.19.1.20636
- By:
- Publication type:
- Article
HIV-TB coinfection impairs CD8<sup>+</sup> T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 9, p. 2529, doi. 10.1002/eji.201545545
- By:
- Publication type:
- Article
Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.
- Published in:
- Bulletin of the World Health Organization, 2015, v. 93, n. 8, p. 529, doi. 10.2471/BLT.14.147447
- By:
- Publication type:
- Article
Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8<sup>+</sup> T-cell responses and disease progression.
- Published in:
- Scientific Reports, 2015, p. 11511, doi. 10.1038/srep11511
- By:
- Publication type:
- Article
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 2, p. 1, doi. 10.1093/ofid/ofv079
- By:
- Publication type:
- Article